BCL2 and neoplasm: Similarly, a recent study suggests that WT1 may potentiate oncogenesis and tumor progression by transcriptionally upregulating BCL2 and that this mechanism may contribute to the heightened resistance to chemotherapy-induced apoptosis in diffuse anaplasia Wilms tumors (27).